35 Materials-Science positions at Center for Drug Evaluation and Research (CDER)

FDA Fellowship in Risk-Based Assessment & Inspections

*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available in the Office of Strategic Programs/Office of Business Informatics, Center for Drug

FDA Research Opportunity for Systematic Review of Drug Safety Program

participation. This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency

FDA Postdoctoral Fellowship in Using Modeling and Simulations to Support Bioequivalence

participation. This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency

FDA Research Fellowship in Over-the-Counter Spray Drug Product

immigration statuses that are acceptable for program participation. This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and

FDA Postdoctoral Glyco-technology Lab Fellowship

Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The participant will receive a monthly stipend commensurate with educational level and experience

FDA Fellowship in Program, Policy and Operational Analysis

science research. Appointment Length: The appointment will initially be for one year, but may be renewed upon recommendation of FDA and is contingent on the availability of funds. Level of Participation

FDA Bioequivalence of Complex Generic Products Fellowship

immigration statuses that are acceptable for program participation. This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and

FDA Oligonucleotide Research Fellowship

, the participant will participate in data evaluation and documentation, collaborating with their mentor on publications, presentations, or reports to learn effective communication of regulatory science to both

FDA-CDER Fellowship in the Intranasal Administration of Monoclonal Antibodies and other Biological Therapeutics

that are acceptable for program participation. This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established

FDA Advanced Characterization of Biologics Lab Fellowship

stress scenarios which may negatively impact drug products like Insulin, monoclonal antibodies and their respective biosimilars along with reference standard materials in terms of their physiochemical